Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$11.51 - $21.53 $29,926 - $55,978
2,600 New
2,600 $30,000
Q3 2023

Nov 14, 2023

BUY
$16.46 - $19.99 $67,486 - $81,959
4,100 New
4,100 $67,000
Q1 2023

May 15, 2023

BUY
$18.08 - $24.55 $95,823 - $130,115
5,300 New
5,300 $100,000
Q3 2022

Nov 14, 2022

BUY
$22.29 - $35.04 $501,525 - $788,400
22,500 New
22,500 $595,000

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $329M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.